Axogen (AXGN) Non-Current Deffered Revenue (2013 - 2020)
Axogen's (AXGN) quarterly Non-Current Deffered Revenue came in at $12000.0 in Q1 2020, down 64.71% year-on-year from $34000.0 in Q2 2019, and down 20.0% quarter-over-quarter from $15000.0 in Q4 2019.
Axogen (AXGN) Non-Current Deffered Revenue (2013 - 2020) Analysis & Trends
Axogen's Non-Current Deffered Revenue history runs 8 years deep, the most recent figure standing at $12000.0 for Q1 2020.
- On a quarterly basis, Non-Current Deffered Revenue fell 64.71% year-over-year to $12000.0 in Q1 2020; TTM through Mar 2020 was $12000.0, a 64.71% decrease from a year earlier, with the FY2019 full-year figure at $15000.0, down 64.29% from the prior year.
- Non-Current Deffered Revenue declined to $12000.0 in Q1 2020 per AXGN's latest filing, from $15000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $92215.0 in Q4 2016 and bottomed at $12000.0 in Q1 2020.
- The 5-year median for Non-Current Deffered Revenue is $61985.0 (2018), against an average of $57322.6.
- Across the five-year window, Non-Current Deffered Revenue decreased 1.69% in 2016 and tumbled 64.71% in 2020, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $92215.0 in 2016, then fell by 25.17% to $69000.0 in 2017, then plunged by 39.13% to $42000.0 in 2018, then plunged by 64.29% to $15000.0 in 2019, then dropped by 20.0% to $12000.0 in 2020.
- Per Business Quant, the three latest AXGN Non-Current Deffered Revenue figures stand at $12000.0 (Q1 2020), $15000.0 (Q4 2019), and $22000.0 (Q3 2019).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 12,000.00 |
| Dec 31, 2019 | 15,000.00 |
| Sep 30, 2019 | 22,000.00 |
| Jun 30, 2019 | 29,000.00 |
| Mar 31, 2019 | 34,000.00 |
| Dec 31, 2018 | 42,000.00 |
| Sep 30, 2018 | 49,000.00 |
| Jun 30, 2018 | 55,000.00 |
| Mar 31, 2018 | 61,985.00 |
| Dec 31, 2017 | 69,000.00 |
| Sep 30, 2017 | 76,027.00 |
| Jun 30, 2017 | 81,423.00 |
| Mar 31, 2017 | 86,818.00 |
| Dec 31, 2016 | 92,215.00 |
| Sep 30, 2016 | 77,610.00 |
| Jun 30, 2016 | 83,006.00 |
| Mar 31, 2016 | 88,401.00 |
| Dec 31, 2015 | 93,797.00 |
| Sep 30, 2015 | 99,193.00 |
| Jun 30, 2015 | 104,589.00 |